生物活性 | |||
---|---|---|---|
描述 | Bosentan is an endothelin (ET) receptor antagonist for ET-A and ET-B with Ki of 4.7 nM and 95 nM, respectively. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00080457 | Pulmonary Hypertension | Phase 3 | Completed | - | United States, Texas ... 展开 >> Encysive Pharmaceuticals Houston, Texas, United States, 77401 收起 << |
NCT00302211 | Pulmonary Hypertension | Phase 3 | Terminated(Terminated due to s... 展开 >>low enrollment) 收起 << | - | - |
NCT00266903 | - | Completed | - | United States, Georgia ... 展开 >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.81mL 0.36mL 0.18mL |
9.06mL 1.81mL 0.91mL |
18.13mL 3.63mL 1.81mL |
参考文献 |
---|